Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02389530 : Use of Fluorescein Dye for the Removal of Brain Tumors
PhasePhase 1/Phase 2
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

1. Age of 18 or greater

2. Plan for elective removal of a brain tumor at UPMC Shadyside with either Dr. Engh or
Dr. Amankulor.

Exclusion Criteria:

1. History of adverse reaction to fluorescein.

2. Emergent surgical procedure (consent not feasible).

3. Creatinine of > 2.0 (drug is excreted renally).

4. Known ongoing pregnancy.
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557